Activation of the endocannabinoid/CB1R system inhibits fatty acid β‐oxidation in the liver (Osei‐Hyiaman et al, 2008), interrupts hepatic carbohydrate and cholesterol metabolism (Jourdan et al, 2012), and contributes to diet‐induced obesity and NAFLD. This evidence concerns the gene CNR1 and Obesity.